Back to home » Top Stories » IAC 2010
XVIII International AIDS Conference
IAC 2010 XVIII International AIDS Conference
Reed Messe Wien
Vienna, Austria
July 18-23, 2010

emailprint

At Least 31 Countries Deporting People Living With HIV

July 20, 2010

By Tim Horn

At least 31 countries still deport people living with HIV, according to a survey of 197 countries conducted by Deutsche AIDS-Hilfe and Human Rights Watch reported on Tuesday, July 20, at the XVIII International AIDS Conference in Vienna.

According to Peter Weissner of Deutsch AIDS-Hilfe, a Germany-based HIV education and advocacy organization, who presented the survey results in Vienna, the actual number of countries deporting migrants with HIV is not precisely known because of the absence of a universal system of reporting and monitoring.

New findings from CAPRISA indicate an experimental microbicide helps reduce risk of HIV infection.  

Cover image from "Returned to Risk: Deportation of HIV-Positive Migrants," a 2009 report by Human Rights Watch.

 

In 2007, Deutsche AIDS-Hilfe developed a questionnaire on HIV-related restrictions on entry, stay and residence, including questions on deportation. With support of the German Ministry for Foreign Affairs, the questionnaire was sent to German embassies of 197 countries.

Human Rights Watch conducted its own survey of deportation of HIV-positive migrants in five countries.

Of the countries surveyed, 31 said they deported people living with HIV. In alphabetical order, these countries are Armenia, Bahrain, Bangladesh, Brunei, Egypt, Equatorial Guinea, Hungary, India, Iraq, Jordan, Kazakhstain, Korea (North and South), Kuwait, Malaysia, Moldova, Mongolia, Oman, Panama, Qatar, Russia, Saudi Arabia, Singapore, Solomon Islands, Sri Lanka, Syria, Taiwan, Turkmenistan, United Arab Emirates, Uzbekistan and Yemen.

An additional 66 countries listed some restrictions, Weissner reported. Twenty-five countries surveyed provided contradictory information, and eight countries didn’t provide any information. Of the 197 surveyed, 119 did not have any migrant restrictions.

Weissner also provided specific examples of deportation practices. In Egypt, for example, 722 HIV-positive foreigners were detected between 1986 and 2006—all of whom have been deported (90 percent were Africans). In South Korea, 521 of 546 HIV-positive foreigners were forced to leave. And in the Russian Federation, 1,579 legal migrants tested positive for HIV in 2008, and 198 of them were deported.

In Saudi Arabia and the United Arab Emirates, there is a high number of mostly Asian migrant workers, all of whom are subjected to mandatory HIV testing. If HIV test results are found to be positive, migrants face detention in prison-like hospital cells for up to one year without treatment. “Many HIV-positive people die while waiting deportation,” Weissner said. In 2008, he added, 1,518 people living with HIV, hepatitis B and tuberculosis were deported from the United Arab Emirates alone.

“Governments have inconsistent policies regarding equitable and non-discriminatory access to HIV treatment and largely fail to ensure linkage to treatment when people living with HIV are deported,” Weissner and his colleagues reported.

“The deportation of people living with HIV based on HIV status itself has no public health justification, and policies that support it are discriminatory and threaten lives,” the authors add. “At the global level it endangers the goal for universal access.”

As for next steps, Weissner said that further research and advocacy are needed and that better recording systems should be put in place. Most important, national governments should reconsider deportation policies for people living with HIV. Migrants should also be provided with a core minimum of health services—including antiretroviral therapy—without discrimination on the basis of citizenship.

More information is available at hivrestrictions.org and hrw.org/en/topic/health/hiv/tb.

Search: Deutsche AIDS-Hilfe, Human Rights Watch, deportation, migrants, immigrants, discrimination, Armenia, Bahrain, Bangladesh, Brunei, Egypt, Equatorial Guinea, Hungary, India, Iraq, Jordan, Kazakhstain, Korea (North and South), Kuwait, Malaysia, Moldova, Mongolia, Oman, Panama, Qatar, Russia, Saudi Arabia, Singapore, Solomon Islands, Sri Lanka, Syria, Taiwan, Turkmenistan, United Arab Emirates, Uzbekistan, Yemen, Vienna, International AIDS Conference, Weissner

Scroll down to comment on this story.

emailprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       

More from AIDS2010

HIV/AIDS Complications

July 28, 2010
Global Survey: Stigma, Isolation and Discrimination Still Pervasive
Universal HIV Treatment Access No Guarantee of Health for Socially Disadvantaged
July 27, 2010
OM-85 BV: A Bacterial Vaccine Against Respiratory Problems in People with HIV and COPD?
Low Vitamin D Levels Not Associated With HIV Drugs
July 23, 2010
Longer Duration of HIV Infection Might Increase the Risk of Brain Disorders
Nearly 75 Percent of People With HIV Might Have Bone Problems
July 22, 2010
Health Care Providers and People With HIV Not Communicating Effectively
July 21, 2010
Non-AIDS Cancers Occurring at Earlier Age Among People With HIV
Hep C Treatment Effective in HIV Patients With Normal Liver Enzymes
Aging Might Have a Smaller Impact on Immune Function Than Suspected
July 20, 2010
Viramune Boosts Hep C Treatment Efficacy in People With HIV
HIV/HCV Coinfection Further Increases Risk of Bone Fractures
Fewer Malignancies Seen in Those Taking Selzentry

Experimental HIV Drugs

July 23, 2010
More Details of TBR-652’s Antiviral and Anti-Inflammatory Potential Reported
July 22, 2010
ViiV HIV Integrase Inhibitor Performing Well in First-Time Treatment Study
Rilpivirine Has Similar Efficacy and Better Tolerability Than Sustiva
Extended-Release Viramune Has Comparable Safety and Efficacy to Standard Viramune
July 20, 2010
New ViiV Integrase Inhibitor Effective Against Some Isentress-Resistant HIV Strains
July 19, 2010
Argos’s Dendritic Cell Therapy Reduces HIV During Treatment Interruption

HIV Transmission and Prevention

July 29, 2010
Prevention Is Failing to Target MSM When They’re Young Enough
July 26, 2010
HPV Cancer Vaccine Effective for Heterosexual, Gay and Bisexual Men
Study Finds PrEP Is Safe in Gay and Bi Men
July 23, 2010
Circumcision Unlikely to Have Major HIV Prevention Benefit Among Gay Men
July 21, 2010
Microbicide Success Story: What It Means and Where We Go Next
MACS: Childhood Sex Abuse and Victimization Linked to Increased HIV Risk
Full-Scale HIV Treatment and Prevention Could Save Millions of Lives
July 20, 2010
Tenofovir Microbicidal Gel Significantly Cuts HIV Infection Rate
HIV Cases in Young People Are Falling Around the World
July 19, 2010
Preliminary Results Suggest Good Safety and Adherence Profile for PrEP

Starting and Switching Treatment

July 22, 2010
Reyataz/Isentress Combo Spares Norvir and Nukes, But Is Integrase Resistance a Concern?
Possibly No Survival Benefit to Starting HIV Treatment at CD4s of 500 or More
Once-Daily Prezista/Norvir Monotherapy Largely Effective Over 96 Weeks
Abacavir/Lamivudine Equivalent to Tenofovir/Emtricitabine in Canadian Cohort Study
July 19, 2010
Strategies for a Cure Reviewed in Vienna
Kaletra/Isentress Shows Promise as HIV Nuceleoside-Sparing Regimen for First-Line Treatment
Switch From Sustiva to Intelence Reduces Central Nervous System Side Effects
Protease Inhibitor-to-Isentress Switch is Effective, Lipid Friendly

Global HIV/AIDS

July 22, 2010
Health Care Providers and People With HIV Not Communicating Effectively
July 20, 2010
Tenofovir Microbicidal Gel Significantly Cuts HIV Infection Rate
5.2 Million People With HIV in Low- and Middle-Income Countries Now on Treatment
At Least 31 Countries Deporting People Living With HIV
HIV Cases in Young People Are Falling Around the World


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.